FDA grants orphan drug designation to Medicovestor’s first-in-class ADC for pancreatic cancer

Boan receives FDA IND clearance for Its CD228-directed ADC

SunRock Biopharma and Escugen forge alliance to develop first-in-class CCR9-targeted ADC

NextCure and Simcere Zaiming announce strategic partnership for a novel antibody-drug conjugate targeting CDH6

IDeate-Prostate01 Phase 3 trial of Ifinatamab Deruxtecan initiated in patients with pretreated metastatic castration-resistant prostate...

Debiopharm’s ADC research gains momentum with launch of first-in-human trial assessing Debio 1562M in acute...